Height-dependent and height-independent bSCr estimation methods were comparable. This may have significant implications for performing pediatric AKI research using large databases, and in clinical care to define AKI when height is unknown.
Background:The progression from acute kidney injury (AKI) to chronic kidney disease
(CKD) is not well understood in children.Objectives:We aimed to develop a pediatric CKD definition using administrative data and
use it to evaluate the association between AKI in critically ill children
and CKD 5 years after hospital discharge.Design:Retrospective cohort study using chart collection and administrative
data.Setting:Two-center study in Montreal, Canada.Patients:Children (≤18 years old) admitted to two pediatric intensive care units
(ICUs) between 2003 and 2005. We a priori excluded patients with end-stage
renal disease or no health care number. Only the first admission during the
study period was included. We excluded patients who could not be linked to
administrative data, did not survive hospitalization, or had preexisting
renal disease.Measurements:Acute kidney injury was defined using Kidney Disease: Improving Global
Outcomes (KDIGO) criteria. Patients were defined as having CKD 5 years
post-discharge if they had ≥1 CKD diagnostic code or ≥1 CKD-specific
medication prescription.Methods:Chart data used to define the exposure (AKI) were merged with provincial
administrative data used to define the outcome (CKD). Cox regression was
used to evaluate the AKI-CKD association.Results:A total of 2235 (56% male) patients were included, and the median admission
age was 3.7 years. A total of 464 (21%) patients developed AKI during
pediatric ICU admission. At 5 years post-discharge, 43 (2%) patients had a
CKD diagnosis. Patients with both stage 1 and stage 2-3 AKI had increased
risk of a CKD diagnosis, with the adjusted hazard ratios (95% confidence
intervals) of 2.2 (1.1-4.5) and 2.5 (1.1-5.7), respectively
(P < .001).Limitations:Results may not be generalizable to non-ICU patients. We were not able to
control for post-discharge variables; future research should try to explore
these additional potential risk factors further.Conclusions:Acute kidney injury is associated with 5-year post-discharge CKD diagnosis
defined by administrative health care data.
AKI is associated with 5- to 7-year mortality. Because this is an observational study we cannot determine if AKI is causative of mortality or of the pathophysiology. However, patients with AKI represent a high-risk group. It is reasonable that these patients be considered for targeted follow-up until future researchers better elucidate these relationships.
Less than half the PICU population had serum creatinine measured before hospital discharge. More severe acute kidney injury was associated with higher likelihood of serum creatinine monitoring and lower probability of acute kidney injury recovery. Future research should address knowledge translation on post-PICU acute kidney injury follow-up before hospital discharge.
Using standardized outcome definitions, children treated with cisplatin, carboplatin, or ifosfamide have a high prevalence of late kidney abnormalities. Research must elucidate best practice for post-cancer treatment follow-up and kidney complication treatment.
Background
With advances in care, neonates undergoing cardiac repairs are surviving more frequently. Our objectives were to 1) estimate the prevalence of chronic kidney disease (CKD) and hypertension 6 years after neonatal congenital heart surgery and 2) determine if cardiac surgery-associated acute kidney injury (CS-AKI) is associated with these outcomes.
Methods
Two-center prospective, longitudinal single-visit cohort study including children with congenital heart disease surgery as neonates between January 2005 and December 2012. CKD (estimated glomerular filtration rate < 90 mL/min/1.73m2 or albumin/creatinine ≥3 mg/mmol) and hypertension (systolic or diastolic blood pressure ≥ 95th percentile for age, sex, and height) prevalence 6 years after surgery was estimated. The association of CS-AKI (Kidney Disease: Improving Global Outcomes definition) with CKD and hypertension was determined using multiple regression.
Results
Fifty-eight children with median follow-up of 6 years were evaluated. CS-AKI occurred in 58%. CKD and hypertension prevalence were 17% and 30%, respectively; an additional 15% were classified as having elevated blood pressure. CS-AKI was not associated with CKD or hypertension. Classification as cyanotic postoperatively was the only independent predictor of CKD. Postoperative days in hospital predicted hypertension at follow-up.
Conclusions
The prevalence of CKD and hypertension is high in children having neonatal congenital heart surgery. This is important; early identification of CKD and hypertension can improve outcomes. These children should be systematically followed for the evolution of these negative outcomes. CS-AKI defined by current standards may not be a useful clinical tool to decide who needs follow-up and who does not.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.